449 results on '"GRIMAUDO, S."'
Search Results
2. SIRT5 rs12216101 T>G variant is associated with oxidative stress and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
3. Hepatocyte depletion of ERK5 impairs the response to lipotoxic oxidative stress resulting in defective insulin receptor signaling
4. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
5. OC.08.1 PROGRAMMED CELL DEATH 1 GENETIC VARIANT AND LIVER DAMAGE IN NONALCOHOLIC FATTY LIVER DISEASE
6. OC-06A cholestatic pattern predicts liver-related events in patients with nonalcoholic fatty liver disease
7. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C
8. OC.09.4 PREVALENCE OF NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) IN INFLAMMATORY BOWEL DISEASE: THE ROLE OF METABOLIC FACTORS, INTESTINAL INFLAMMATION AND GENETIC PHENOTYPE
9. Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD
10. GEMS, a GEnetic and Metabolic Staging predicting the outcome of non-alcoholic fatty liver disease
11. A cholestatic pattern predicts liver outcomes in patients with nonalcoholic fatty liver disease
12. SIRT5 rs12216101 T>G variant is associated with fibrosis severity in patients with non-alcoholic fatty liver disease
13. NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease
14. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients
15. Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices
16. T04.01.11 PREVALENCE OF NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) IN INFLAMMATORY BOWEL DISEASE: THE IMPACT OF TRADITIONAL RISK FACTORS, INTESTINAL INFLAMMATION AND GENETIC PHENOTYPE
17. PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver
18. A cholestatic pattern predicts liver outcomes in patients with nonalcoholic fatty liver disease
19. PNPLA3 rs738409 C >G variant is associated with a higher risk of liver fibrosis progression assessed by FIB-4 and stiffness by fibroscan in patients with non-alcoholic fatty liver disease
20. P162 Prevalence of nafld (non alcoholic fatty liver disease) and fibrosis in inflammatory bowel disease: the impact of traditional risk factors, intestinal inflammation and genetic phenotype
21. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
22. Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms
23. Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients
24. FXR rs35724 G>C variant modulates cholesterol levels, carotid atherosclerosis and liver damage in non-alcoholic fatty liver
25. AA genotype of deSNP rs6726639 of MERTK gene is associated with development of Hepatocellular Carcinoma after eradication of Hepatitis C Virus infection
26. PNPLA3 rs738409 C>G variant predicts occurrence of liver-related events and death in non-alcoholic fatty liver
27. Effects of HCV eradication by DAA on oxidative stress parameters in patients with chronic hepatitis C
28. Changes in 13C-aminopyrine breath test predict liver-related events and death in patients with HCV-related previous decompensated child A5 or child A6 to B cirrhosis who achieve SVR after DAA therapy
29. Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity
30. NS5A gene analysis by next generation sequencing in HCV nosocomial transmission clusters of HCV genotype 1b infected patients
31. Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease
32. Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in Mediterranean area
33. Apoptotic effects of thiazolobenzimidazole derivatives on sensitive and multidrug resistant leukaemic cells
34. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
35. TM6SF2gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
36. Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV
37. PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE
38. Liver follicular helper T-cells in chronic hepatitis C
39. Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins
40. CBS and MTRR mutations, observed in Sicily, in thromboembolic and hyperhomocystemic patients, unresponsive to administration of folate and vitamin B12
41. Hyperhomocysteinemia in thromboembolic disease: role of mthfr,cbs and mtrr mutations in Sicily
42. Methylenetetrahydrofolate reductase mutation in subjects with abdominal aortic aneurysm subdivided for age
43. FNDC5 rs3480 A>G polymorphism disentangles steatosis from fibrosis severity in patients with nonalcoholic fatty liver disease
44. FNDC5 rs3480 A > G Polymorphism Disentangles Steatosis from Fibrosis Severity in Patients with Non-Alcoholic Fatty Liver Disease
45. Genotypic and phenotypic factors in ischemic stroke in young adults
46. PNPLA3 gene variants and insulin resistance in patients with genotype-1 chronic hepatitis C
47. IL28B rs12979860 CC Genotype, Metabolic Profile and SVR in Patients with Genotype 1 Chronic Hepatitis C
48. IL28B genotype, differential expression of intrahepatis interferon-stimulated genes and response to PEG-IFN and ribavirin therapy in an Italian prospective cohort of genotype 1 hepatitis C patients in 'real life'
49. P0760 : PNPLA3 rs738409 I748M is associated with steatohepatitis in non obese subjects with hepatitis C
50. PNPLA3 RS738409 I748M is associated with steatohepatitis in non obese subjects with hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.